Orris

Fentanyl infusion dose for sedation

Reading File
Finding Sources
Searching PubMed

fentanyl AND sedation

Searching the Web

fentanyl continuous infusion ICU sedation adult dose guideline

Adult ICU, mechanically ventilated: fentanyl is mainly an analgesic, often used as part of analgosedation rather than as the sole sedative.
  • Common starting infusion: 25-50 micrograms/hour IV
  • Titrate in small increments, often 25-50 micrograms/hour, to an objective pain score and light sedation target.
  • Typical protocol range: 25-200 micrograms/hour. Higher doses may be used in opioid-tolerant patients, but require close review.
Avoid a routine bolus in a hemodynamically unstable or opioid-naive patient. Monitor continuous SpO₂, ventilation/EtCO₂ when applicable, blood pressure, consciousness, and signs of chest-wall rigidity, especially with rapid or high-dose administration. Reduce doses in older adults and hepatic impairment; accumulation can occur with prolonged infusions.
For procedural sedation, fentanyl is generally given as intermittent IV doses, not a maintenance infusion: 25-50 micrograms slow IV, titrated cautiously, especially if combined with midazolam or propofol because of respiratory-depression risk. The SCCM PADIS guidance supports protocolized, lowest-effective-dose opioid use for ICU pain management, and the MSD procedural-sedation reference emphasizes cautious titration with other sedatives.
This should be prescribed and titrated under local ICU/anesthesia protocol. Pediatric, non-intubated, and post-operative dosing differs substantially.

Per kg smdose

Reading File
Finding Sources
Searching PubMed

fentanyl AND intensive care sedation

Searching the Web

adult intensive care fentanyl continuous infusion 1 microgram kg hour dosing

For an adult ventilated ICU patient, a typical fentanyl infusion is:
  • Start: 0.5-1 microgram/kg/hour IV
  • Usual titration range: 0.5-3 micrograms/kg/hour IV
  • Titrate by about 0.25-0.5 microgram/kg/hour according to pain score, RASS target, respiratory status, and blood pressure.
Example: 70 kg patient
  • 1 microgram/kg/hour = 70 micrograms/hour
Use lower starting doses in older, frail, opioid-naive, or hepatic-impaired patients. Do not rely on fentanyl alone for amnesia/deep sedation. Monitor closely for respiratory depression, hypotension, bradycardia, chest-wall rigidity, and accumulation with prolonged infusion. A published adult ICU protocol used 0.5-3 micrograms/kg/hour; see this ICU dosing study.

Tx of bleeding due to low platelet count

Reading File
Finding Sources
Searching PubMed

thrombocytopenia AND bleeding

Searching the Web

ASH guideline management bleeding thrombocytopenia platelet transfusion severe bleeding

Reading File
Reading File
Reading Web Page

https://www.hematology.org/-/media/hematology/files/educatio…

Bleeding with thrombocytopenia is treated urgently based on severity and cause.
  1. Active significant bleeding
    • Give platelet transfusion promptly, usually 1 adult apheresis unit.
    • Common target platelet counts:
      • >50 × 10⁹/L for active major bleeding or major surgery
      • >100 × 10⁹/L for intracranial bleeding, eye surgery, or severe head trauma
    • Recheck platelet count after transfusion and repeat if bleeding persists or the rise is inadequate.
  2. Immediate supportive measures
    • Local control: direct pressure, packing, topical hemostatic measures, urgent endoscopy/surgery/interventional radiology as appropriate.
    • Stop anticoagulants and antiplatelet drugs if clinically safe; reverse their effect when indicated.
    • Check and correct other hemostatic defects: PT/INR, aPTT, fibrinogen, hemoglobin, renal/liver function. In major hemorrhage, plasma, cryoprecipitate/fibrinogen, and red cells may be needed depending on results.
    • Consider tranexamic acid only in appropriate bleeding contexts and after assessing thrombosis risk and contraindications.
  3. Treat the cause
    • Immune thrombocytopenia (ITP) with severe/critical bleeding: platelets plus high-dose corticosteroid and IVIG. Platelets alone may be rapidly destroyed.
    • TTP: urgent plasma exchange plus corticosteroids/caplacizumab per hematology. Avoid routine platelets unless bleeding is life-threatening.
    • HIT: stop all heparin and start non-heparin anticoagulation. Avoid routine platelet transfusion, but it may be used for active serious bleeding, as ASH HIT guidance states.
    • DIC/sepsis/massive transfusion: treat the underlying trigger and replace platelets/coagulation factors guided by clinical bleeding and labs.
“Wet” bleeding such as nose or gum bleeding, GI bleeding, hematuria, bleeding from IV sites, or heavy menstrual bleeding is more concerning than petechiae alone. Textbook thresholds support transfusion for active bleeding when platelets are <50 × 10⁹/L, and targeting >100 × 10⁹/L in intracranial hemorrhage. Tintinalli’s Emergency Medicine, pp. 1538-39.
Emergency action: if there is confusion, severe headache, black/bloody stools, vomiting blood, heavy uncontrolled bleeding, breathlessness, fainting, or bleeding after head injury, seek emergency care now.

What to do if bleeding occurs during intubation in patients with platelet of 37000

Reading File
Finding Sources
Searching PubMed

thrombocytopenia AND tracheal intubation

Searching the Web

guideline active airway bleeding thrombocytopenia platelet transfusion intubation platelet count

With a platelet count of 37 × 10⁹/L (37,000/µL) and active bleeding during intubation, treat this as an airway emergency.

Immediate actions

  1. Call for senior airway/anesthesia help, ENT, and blood bank.
  2. Maintain oxygenation and airway patency
    • Suction blood continuously.
    • Use video laryngoscopy if available and minimize repeated attempts/trauma.
    • Avoid nasal instrumentation or blind nasal intubation.
    • Once intubated, confirm tube placement and secure it. If blood/clot obstructs the airway, bronchoscopy may be needed.
  3. Control the visible source
    • Direct pressure with gauze, oral packing if appropriate, and topical vasoconstrictor for nasal/oropharyngeal mucosal bleeding where suitable.
    • Identify whether bleeding is from lips, gums, nose, tongue, pharynx, traumatic laryngoscopy, or lower airway.

Blood product management

  • Give 1 adult therapeutic platelet dose urgently for clinically significant ongoing mucosal/airway bleeding at this count, while arranging crossmatched blood if bleeding is substantial.
  • Aim for platelets >50 × 10⁹/L for active significant bleeding. If there is head trauma, suspected intracranial bleeding, or neurosurgical concern, aim for >100 × 10⁹/L.
  • Check platelet count after transfusion and repeat if the increment is poor or bleeding continues.
  • Send urgent CBC, PT/INR, aPTT, fibrinogen, blood group/crossmatch, and assess for DIC, liver dysfunction, renal failure, anticoagulants, or antiplatelet medicines.
  • Correct associated abnormalities: e.g., fibrinogen deficiency, significant coagulopathy, or anemia according to major-hemorrhage protocol.

Important cause-specific exception

If thrombocytopenia is due to TTP or HIT, platelets are usually avoided because of thrombosis risk, but life-threatening airway bleeding is an exception and requires hematology input. In suspected ITP with severe bleeding, platelets should be combined with IVIG and corticosteroids, because transfused platelets may be rapidly destroyed.
Platelet transfusion is indicated therapeutically in actively bleeding thrombocytopenic patients; emergency references use <50 × 10⁹/L with active bleeding as a common threshold and <100 × 10⁹/L for intracranial hemorrhage. Tintinalli’s Emergency Medicine, p. 1538. Recent critical-care guidance likewise supports platelet transfusion in serious bleeding with platelet counts below roughly 50 × 10⁹/L, tailored to the clinical setting, as summarized in this critical-care transfusion guidance.
If this is occurring now, activate the institution’s difficult-airway and major-hemorrhage protocols immediately.

Can i give tranexmic acid

Reading File
Finding Sources
Searching PubMed

tranexamic acid AND thrombocytopenia bleeding

Searching the Web

tranexamic acid active mucosal airway bleeding thrombocytopenia contraindications guideline

Yes, TXA can be considered as an adjunct for ongoing traumatic oral/oropharyngeal mucosal bleeding during intubation, but it does not replace platelet transfusion and local airway control in a patient with platelets 37,000/µL.
  • For a clearly accessible oral/pharyngeal bleeding point, topical TXA on gauze is often the preferred adjunct, with direct pressure and suction.
  • If bleeding is diffuse, substantial, or there is suspected hyperfibrinolysis, the senior anesthesia/ICU/hematology team may use IV TXA per the local major-hemorrhage protocol.
  • Give platelets concurrently for significant active bleeding, with a practical goal above 50 × 10⁹/L.
Do not give, or obtain urgent senior advice before giving TXA, with:
  • Active or recent arterial/venous thrombosis, including suspected/confirmed HIT with thrombosis
  • Gross hematuria or upper urinary tract bleeding, due to risk of obstructing clot
  • Significant renal impairment without dose adjustment
  • Prior TXA hypersensitivity
  • History of seizures, especially if considering high IV doses
  • Suspected DIC without severe hemorrhage
In this setting: secure the airway, suction continuously, use direct pressure/topical measures, transfuse platelets, and correct fibrinogen/coagulopathy if abnormal. TXA is helpful for mucosal bleeding but should not delay these steps. Topical TXA has evidence for reducing mucosal bleeding, including epistaxis; Tintinalli’s Emergency Medicine describes applying 5-10 mL of 100 mg/mL TXA solution to gauze for direct wound application. TXA needs renal dose reduction and carries a thrombosis risk.

Trenexa dose

Reading File
Finding Sources
Searching the Web

tranexamic acid injection prescribing information adult intravenous dose hemorrhage 1 g slow intravenous topical oral bleeding

Searching PubMed

tranexamic acid AND mucosal bleeding

Trenexa = tranexamic acid (TXA). For the described adult with ongoing traumatic oral/oropharyngeal bleeding during intubation:
  • IV TXA: 1 g IV slowly over 10 minutes
    • Do not give as a rapid IV push.
    • A further regimen depends on the cause and local major-hemorrhage protocol. If this is trauma-related bleeding within 3 hours of injury: 1 g over 10 min, then 1 g IV infusion over 8 hours.
  • Topical TXA for an accessible mucosal bleeding site: use the 100 mg/mL injection to soak gauze with 5-10 mL and apply direct pressure to the site. Use suction and avoid leaving loose gauze in the airway.
For active bleeding with platelets 37,000/µL, TXA is only an adjunct. Give a therapeutic platelet transfusion and target >50,000/µL, while correcting fibrinogen/coagulopathy and controlling the local source.
Avoid or obtain urgent senior advice before TXA if there is active thrombosis, suspected HIT/TTP, gross hematuria, major renal impairment without dose adjustment, or prior seizures. The manufacturer information supports 0.5-1 g slow IV for local fibrinolytic bleeding or 1 g slow IV every 6-8 hours for general fibrinolysis, with renal adjustment, in its TXA product guidance.

If this patients creat is 4 how much i should give and patients weight is 40 kg

Reading File
Finding Sources
Searching the Web

tranexamic acid injection renal impairment serum creatinine 250 500 micromol 10 mg kg every 24 hours product label

Searching PubMed

tranexamic acid AND renal impairment

Assuming creatinine is 4 mg/dL (about 354 µmol/L) and the patient weighs 40 kg:
  • Renal-adjusted IV TXA dose: 10 mg/kg IV once daily
  • Calculation: 10 mg/kg × 40 kg = 400 mg IV once daily
  • Give slowly over about 10 minutes. Do not give rapid IV push.
If using a 100 mg/mL ampoule, 400 mg = 4 mL. Dilute and administer per local policy.
For the current airway-bleeding situation, use TXA only as an adjunct to suction, direct/local hemostasis, urgent platelet transfusion, and correction of coagulopathy. With platelets 37,000/µL and active bleeding, target platelets above 50,000/µL.
Avoid repeated 1 g doses in this patient without senior ICU/anesthesia/hematology approval because TXA is renally cleared and can accumulate, increasing seizure and thrombotic risk. The renal-adjusted manufacturer dosing for serum creatinine 2.83-5.66 mg/dL is 10 mg/kg IV every 24 hours, as stated in this prescribing information.
This is a shared conversation. Sign in to Orris to start your own chat.